Pregabalin add-on for drug-resistant focal epilepsy

This evidence summary presents the best available evidence regarding pregabalin add-on for drug-resistant focal epilepsy.1 Introduction Approximately 3–3.5% of Australians will experience epilepsy at some point...

Call to enlist pharmacists for opioid fight as deaths rise

New Australian Institute of Health and Welfare (AIHW) research has revealed the number of Australian deaths involving opioids has more than doubled in the...

Opioids, antidepressants and the risk of hip fracture

A recent study identified that the risk of hip fracture was increased with the use of psychotropic drugs in elderly people. The highest risk...

Is Australia’s scope of care lagging behind?

Nations around the globe used to look to Australia for examples of bold and innovative pharmacy funding projects. But many of our overseas peers...

Blockchain exec pushing for the end of paper prescriptions

Australian laws requiring use of paper documents prevent new technological solutions that could inhibit prescription fraud. That’s the diagnosis of Dr Tal Rapke, chief executive...

Minor Ailments Scheme gets 10/10 from Scottish patients

A new report indicates the ‘undeniable popularity’ of Scotland’s Minor Ailment Scheme (MAS), as support swells amongst pharmacy groups for its implementation in Australia....